| Year |
Citation |
Score |
| 2018 |
Cumming TB, Yeo AB, Marquez J, Churilov L, Annoni JM, Badaru U, Ghotbi N, Harbison J, Kwakkel G, Lerdal A, Mills R, Naess H, Nyland H, Schmid A, Tang WK, et al. Investigating post-stroke fatigue: An individual participant data meta-analysis. Journal of Psychosomatic Research. 113: 107-112. PMID 30190042 DOI: 10.1016/J.Jpsychores.2018.08.006 |
0.537 |
|
| 2017 |
Grytten N, Skår AB, Aarseth JH, Assmus J, Farbu E, Lode K, Nyland HI, Smedal T, Myhr KM. The influence of coping styles on long-term employment in multiple sclerosis: A prospective study. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 1008-1017. PMID 27600114 DOI: 10.1177/1352458516667240 |
0.581 |
|
| 2015 |
Nyland H, Næss H, Nyland M. [Mapping of function in chronic fatigue syndrome]. Tidsskrift For Den Norske Laegeforening : Tidsskrift For Praktisk Medicin, Ny Raekke. 135: 1540-1. PMID 26394583 DOI: 10.4045/Tidsskr.15.0530 |
0.524 |
|
| 2014 |
Nyland M, Naess H, Birkeland JS, Nyland H. Longitudinal follow-up of employment status in patients with chronic fatigue syndrome after mononucleosis. Bmj Open. 4: e005798. PMID 25428629 DOI: 10.1136/Bmjopen-2014-005798 |
0.535 |
|
| 2014 |
Jacobsen C, Hagemeier J, Myhr KM, Nyland H, Lode K, Bergsland N, Ramasamy DP, Dalaker TO, Larsen JP, Farbu E, Zivadinov R. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study Journal of Neurology, Neurosurgery, and Psychiatry. 85: 1109-1115. PMID 24554101 DOI: 10.1136/Jnnp-2013-306906 |
0.605 |
|
| 2014 |
Klevan G, Jacobsen CO, Aarseth JH, Myhr KM, Nyland H, Glad S, Lode K, Figved N, Larsen JP, Farbu E. Health related quality of life in patients recently diagnosed with multiple sclerosis Acta Neurologica Scandinavica. 129: 21-26. PMID 23772958 DOI: 10.1111/Ane.12142 |
0.415 |
|
| 2013 |
Naess H, Nyland H, Idicula T, Waje-Andreassen U. C-reactive protein and homocysteine predict long-term mortality in young ischemic stroke patients. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 22: e435-40. PMID 23735372 DOI: 10.1016/J.Jstrokecerebrovasdis.2013.04.031 |
0.543 |
|
| 2013 |
Naess H, Nyland H. Poststroke fatigue and depression are related to mortality in young adults: a cohort study. Bmj Open. 3. PMID 23457330 DOI: 10.1136/Bmjopen-2012-002404 |
0.541 |
|
| 2013 |
Naess H, Nyland H. Poor health-related quality of life is associated with long-term mortality in young adults with cerebral infarction. Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association. 22: e79-83. PMID 22877691 DOI: 10.1016/J.Jstrokecerebrovasdis.2012.06.010 |
0.544 |
|
| 2012 |
Naess H, Nyland M, Hausken T, Follestad I, Nyland HI. Chronic fatigue syndrome after Giardia enteritis: clinical characteristics, disability and long-term sickness absence. Bmc Gastroenterology. 12: 13. PMID 22316329 DOI: 10.1186/1471-230X-12-13 |
0.535 |
|
| 2012 |
Svendsen B, Myhr K, Nyland HI, Aarseth JH. The cost of multiple sclerosis in Norway European Journal of Health Economics. 13: 81-91. PMID 21080024 DOI: 10.1007/S10198-010-0286-7 |
0.491 |
|
| 2011 |
Fluge Ø, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, Næss H, Dahl O, Nyland H, Mella O. Benefit from b-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. a double-blind and placebo-controlled study Plos One. 6. PMID 22039471 DOI: 10.1371/Journal.Pone.0026358 |
0.578 |
|
| 2011 |
Risberg G, Aarseth JH, Nyland H, Lauer K, Myhr KM, Midgard R. Prevalence and incidence of multiple sclerosis in Oppland County: a cross-sectional population-based study in a landlocked county of Eastern Norway. Acta Neurologica Scandinavica. 124: 250-7. PMID 21143594 DOI: 10.1111/J.1600-0404.2010.01465.X |
0.619 |
|
| 2011 |
Glad SB, Nyland H, Aarseth JH, Riise T, Myhr KM. How long can you keep working with benign multiple sclerosis? Journal of Neurology, Neurosurgery, and Psychiatry. 82: 78-82. PMID 20802029 DOI: 10.1136/Jnnp.2010.210732 |
0.627 |
|
| 2010 |
Ramagopalan SV, Hanwell HE, Giovannoni G, Knappskog PM, Nyland HI, Myhr KM, Ebers GC, Torkildsen O. Vitamin D-dependent rickets, HLA-DRB1, and the risk of multiple sclerosis. Archives of Neurology. 67: 1034-5. PMID 20697062 DOI: 10.1001/Archneurol.2010.182 |
0.472 |
|
| 2010 |
Glad SB, Aarseth JH, Nyland H, Riise T, Myhr K-. Benign multiple sclerosis: a need for a consensus Acta Neurologica Scandinavica. 122: 44-50. PMID 20586735 DOI: 10.1111/J.1600-0404.2010.01375.X |
0.431 |
|
| 2010 |
Naess H, Sundal E, Myhr KM, Nyland HI. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo (Athens, Greece). 24: 185-8. PMID 20363992 |
0.636 |
|
| 2009 |
Lode K, Bru E, Klevan G, Myhr KM, Nyland H, Larsen JP. Coping with multiple sclerosis: a 5‐year follow‐up study Acta Neurologica Scandinavica. 122: 336-342. PMID 20047563 DOI: 10.1111/J.1600-0404.2009.01313.X |
0.451 |
|
| 2009 |
Glad S, Nyland H, Aarseth J, Riise T, Myhr K. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway. Multiple Sclerosis Journal. 15: 942-950. PMID 19570821 DOI: 10.1177/1352458509106511 |
0.644 |
|
| 2009 |
Lode K, Bru E, Klevan G, Myhr K, Nyland H, Larsen J. Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis Multiple Sclerosis Journal. 15: 638-643. PMID 19299438 DOI: 10.1177/1352458509102313 |
0.606 |
|
| 2009 |
Midgard R, Glattre E, Grønning M, Riise T, Edland A, Nyland H. Multiple sclerosis and cancer in Norway. A retrospective cohort study. Acta Neurologica Scandinavica. 93: 411-415. PMID 8836302 DOI: 10.1111/J.1600-0404.1996.Tb00019.X |
0.362 |
|
| 2009 |
Howlett WP, Vedeler CA, Nyland H, Aarli JA. Guillain‐Barré syndrome in northern Tanzania: a comparison of epidemiological and clinical findings with western Norway Acta Neurologica Scandinavica. 93: 44-49. PMID 8825272 DOI: 10.1111/J.1600-0404.1996.Tb00169.X |
0.529 |
|
| 2009 |
Midgard R, Grønning M, Riise T, Kvåle G, Nyland H. Multiple sclerosis and chronic inflammatory diseases A case‐control study Acta Neurologica Scandinavica. 93: 322-328. PMID 8800342 DOI: 10.1111/J.1600-0404.1996.Tb00004.X |
0.432 |
|
| 2009 |
Midgard R, Riise T, Kvåle G, Nyland H. Disability and mortality in multiple sclerosis in western Norway. Acta Neurologica Scandinavica. 93: 307-314. PMID 8800339 DOI: 10.1111/J.1600-0404.1996.Tb00001.X |
0.389 |
|
| 2009 |
Edland A, Nyland H, Riise T, Larsen JP. Epidemiology of multiple sclerosis in the county of Vestfold, eastern Norway: incidence and prevalence calculations. Acta Neurologica Scandinavica. 93: 104-109. PMID 8741127 DOI: 10.1111/J.1600-0404.1996.Tb00183.X |
0.403 |
|
| 2009 |
Grønning M, Albrektsen G, Kvåle G, Moen B, Aarli JA, Nyland H. Organic solvents and multiple sclerosis : a case-control study Acta Neurologica Scandinavica. 88: 247-250. PMID 8256566 DOI: 10.1111/J.1600-0404.1993.Tb04229.X |
0.593 |
|
| 2009 |
Brokstad KA, Page M, Nyland H, Haaheim LR. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients Acta Neurologica Scandinavica. 89: 407-411. PMID 7526591 DOI: 10.1111/J.1600-0404.1994.Tb02657.X |
0.435 |
|
| 2009 |
Næss A, Nyland H. Effect of AET treatment of sheep erythrocytes on the rosette test in various diseases. Acta Pathologica Microbiologica Scandinavica Series C: Immunology. 90: 327-330. PMID 6985001 DOI: 10.1111/J.1699-0463.1982.Tb01458.X |
0.328 |
|
| 2009 |
Aasjord P, Nyland H. Antibodies to staphylococcal lipoteichoic acid in serum and in cerebrospinal fluid from patients with multiple sclerosis. Acta Pathologica Microbiologica Scandinavica Section C Immunology. 89: 333-338. PMID 6797247 DOI: 10.1111/J.1699-0463.1981.Tb02709.X |
0.404 |
|
| 2009 |
Larsen JP, Kvaale G, Riise T, Nyland H, Aarli JA. An increase in the incidence of multiple sclerosis in western Norway. Acta Neurologica Scandinavica. 70: 96-103. PMID 6333133 DOI: 10.1111/J.1600-0404.1984.Tb00809.X |
0.566 |
|
| 2009 |
Næss A, Nyland H. Effect of ACTH treatment on CSF and blood lymphocyte subpopulations in patients with multiple sclerosis Acta Neurologica Scandinavica. 63: 57-66. PMID 6258379 DOI: 10.1111/J.1600-0404.1981.Tb00749.X |
0.337 |
|
| 2009 |
Larsen JP, Kvaale G, Riise T, Nyland H, Aarli JA. Multiple sclerosis--more than one disease? Acta Neurologica Scandinavica. 72: 145-150. PMID 4050323 DOI: 10.1111/J.1600-0404.1985.Tb00856.X |
0.63 |
|
| 2009 |
Larsen JP, Riise T, Nyland H, Kvale G, Aarli JA. Clustering of multiple sclerosis in the county of Hordaland, Western Norway. Acta Neurologica Scandinavica. 71: 390-395. PMID 4013662 DOI: 10.1111/J.1600-0404.1985.Tb03218.X |
0.571 |
|
| 2009 |
Aarli JA, Vaernes R, Brubakk AO, Nyland H, Skeidsvoll H, Tønjum S. Central nervous dysfunction associated with deep-sea diving. Acta Neurologica Scandinavica. 71: 2-10. PMID 3976349 DOI: 10.1111/J.1600-0404.1985.Tb03159.X |
0.533 |
|
| 2009 |
Larsen JP, Kvale G, Nyland H. Epidemiology of the Guillain-Barré syndrome in the county of Hordaland, Western Norway. Acta Neurologica Scandinavica. 71: 43-47. PMID 3872003 DOI: 10.1111/J.1600-0404.1985.Tb03165.X |
0.381 |
|
| 2009 |
Aasjord P, Nyland H, Haaheim LR. Intrathecal synthesis of antibodies to staphylococcal antigens in multiple sclerosis patients. Acta Pathologica Microbiologica Scandinavica Series C: Immunology. 94: 97-103. PMID 3751587 DOI: 10.1111/J.1699-0463.1986.Tb02097.X |
0.39 |
|
| 2009 |
Vedeler CA, Nyland H. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies. Acta Neurologica Scandinavica. 82: 147-149. PMID 2256446 DOI: 10.1111/J.1600-0404.1990.Tb01606.X |
0.312 |
|
| 2009 |
Nyland H, Aarli JA. Guillain‐Barré syndrome: Demonstration of antibodies to peripheral nerve tissue Acta Neurologica Scandinavica. 58: 35-43. PMID 707033 DOI: 10.1111/J.1600-0404.1978.Tb02857.X |
0.529 |
|
| 2009 |
Nyland H, Naess A. T lymphocytes in peripheral blood from patients with neurological diseases. Acta Neurologica Scandinavica. 58: 272-279. PMID 310624 DOI: 10.1111/J.1600-0404.1978.Tb02887.X |
0.37 |
|
| 2009 |
Larsen JP, Riise T, Kvaale G, Nyland H, Aarli JA. MS in Hordaland, Western Norway: An increasing frequency of the disease Acta Neurologica Scandinavica. 69: 372-373. DOI: 10.1111/J.1600-0404.1984.Tb02524.X |
0.588 |
|
| 2009 |
Næss A, Nyland H, Glette J, Rygh T, Larsen JP. Granulocyte function in patients with multiple sclerosis (MS) Acta Neurologica Scandinavica. 69: 353-354. DOI: 10.1111/J.1600-0404.1984.Tb02514.X |
0.435 |
|
| 2009 |
Nyland H, and RMA, Mörk S. Characterization of mononuclear cell infiltrates in the multiple sclerosis lesion Acta Neurologica Scandinavica. 63: 141-141. DOI: 10.1111/J.1600-0404.1981.Tb00761.X |
0.309 |
|
| 2008 |
Figved N, Benedict R, Klevan G, Myhr KM, Nyland HI, Landrø NI, Larsen JP, Aarsland D. Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 14: 1084-90. PMID 18728059 DOI: 10.1177/1352458508092262 |
0.596 |
|
| 2008 |
Torkildsen NG, Lie S, Aarseth J, Nyland H, Myhr K. Survival and cause of death in multiple sclerosis : results from a 50-year follow-up in Western Norway Multiple Sclerosis Journal. 14: 1191-1198. PMID 18632781 DOI: 10.1177/1352458508093890 |
0.606 |
|
| 2008 |
Torkildsen Ø, Knappskog PM, Nyland HI, Myhr KM. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Archives of Neurology. 65: 809-11. PMID 18541802 DOI: 10.1001/Archneur.65.6.809 |
0.5 |
|
| 2008 |
Yu X, Koczan D, Sulonen AM, Akkad DA, Kroner A, Comabella M, Costa G, Corongiu D, Goertsches R, Camina-Tato M, Thiesen HJ, Nyland HI, Mørk SJ, Montalban X, Rieckmann P, et al. mtDNA nt13708A variant increases the risk of multiple sclerosis. Plos One. 3: e1530. PMID 18270557 DOI: 10.1371/Journal.Pone.0001530 |
0.526 |
|
| 2007 |
Torkildsen Ø, Nyland H, Myrmel H, Myhr K-. Epstein-Barr virus reactivation and multiple sclerosis. European Journal of Neurology. 15: 106-108. PMID 18042233 DOI: 10.1111/J.1468-1331.2007.02009.X |
0.398 |
|
| 2007 |
Lode K, Larsen JP, Bru E, Klevan G, Myhr KM, Nyland H. Patient information and coping styles in multiple sclerosis. Multiple Sclerosis Journal. 13: 792-799. PMID 17613608 DOI: 10.1177/1352458506073482 |
0.387 |
|
| 2007 |
Nortvedt MW, Riise T, Frugaård J, Mohn J, Bakke A, Skår AB, Nyland H, Glad SB, Myhr K. Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis. Multiple Sclerosis Journal. 13: 106-112. PMID 17294618 DOI: 10.1177/1352458506071210 |
0.366 |
|
| 2006 |
Glad S, Nyland H, Myhr K-. Benign multiple sclerosis. Acta Neurologica Scandinavica. 113: 55-57. PMID 16637931 DOI: 10.1111/J.1600-0404.2006.00617.X |
0.416 |
|
| 2006 |
Myhr K-, Grytten N, Aarseth JH, Nyland H. The Norwegian Multiple Sclerosis National Competence Centre and National Multiple Sclerosis registry -- a resource for clinical practice and research. Acta Neurologica Scandinavica. 113: 37-40. PMID 16637927 DOI: 10.1111/J.1600-0404.2006.00613.X |
0.424 |
|
| 2006 |
Naess H, Waje-Andreassen U, Thomassen L, Nyland H, Myhr KM. Health-related quality of life among young adults with ischemic stroke on long-term follow-up. Stroke. 37: 1232-6. PMID 16601213 DOI: 10.1161/01.Str.0000217652.42273.02 |
0.648 |
|
| 2005 |
Figved N, Klevan G, Myhr KM, Glad S, Nyland H, Larsen JP, Harboe E, Omdal R, Aarsland D. Neuropsychiatric symptoms in patients with multiple sclerosis Acta Psychiatrica Scandinavica. 112: 463-468. PMID 16279876 DOI: 10.1111/J.1600-0447.2005.00624.X |
0.423 |
|
| 2005 |
Naess H, Nyland HI, Thomassen L, Aarseth J, Myhr KM. Fatigue at long-term follow-up in young adults with cerebral infarction. Cerebrovascular Diseases (Basel, Switzerland). 20: 245-50. PMID 16123544 DOI: 10.1159/000087706 |
0.632 |
|
| 2005 |
Wergeland S, Beiske A, Nyland H, Hovdal H, Jensen D, Larsen JP, Marøy TH, Smievoll A‐, Vedeler CA, Myhr K‐. IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis. European Journal of Neurology. 12: 171-175. PMID 15693804 DOI: 10.1111/J.1468-1331.2004.01102.X |
0.329 |
|
| 2004 |
Oturai AB, Ryder LP, Fredrikson S, Myhr KM, Celius EG, Harbo HF, Andersen O, Akesson E, Hillert J, Madsen HO, Nyland H, Spurkland A, Datta P, Svejgaard A, Sorensen PS. Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs. Multiple Sclerosis (Houndmills, Basingstoke, England). 10: 5-8. PMID 14760946 DOI: 10.1191/1352458504Ms975Oa |
0.597 |
|
| 2004 |
Ulvestad E, Aarseth JH, Vedeler C, Nyland H, Myhr K-. The Effects of Interferon-α2a on Concentrations of Immunoglobulins, Complement and Lymphocytes in Patients with Multiple Sclerosis Scandinavian Journal of Immunology. 59: 103-108. PMID 14723628 DOI: 10.1111/J.0300-9475.2004.01360.X |
0.363 |
|
| 2003 |
Dahl OP, Aarseth JH, Myhr KM, Nyland H, Midgard R. Multiple sclerosis in Nord-Trøndelag County, Norway: a prevalence and incidence study. Acta Neurologica Scandinavica. 109: 378-384. PMID 15147459 DOI: 10.1111/J.1600-0404.2004.00244.X |
0.345 |
|
| 2003 |
Bø L, Vedeler CA, Nyland H, Trapp BD, Mørk SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Multiple Sclerosis (Houndmills, Basingstoke, England). 9: 323-31. PMID 12926836 DOI: 10.1191/1352458503Ms917Oa |
0.327 |
|
| 2003 |
Eriksen E, Haugstad R, Aarseth JH, Myhr K, Nyland H. Interferon-beta Treatment in Multiple Sclerosis; Patients’ Experience in the First 100 Patients Acta Neurologica Scandinavica. 107: 429-430. DOI: 10.1034/J.1600-0404.2003.00125_9.X |
0.553 |
|
| 2002 |
Fernandes Filho JA, Vedeler CA, Myhr KM, Nyland H, Pandey JP. TNF-alpha and -beta gene polymorphisms in multiple sclerosis: a highly significant role for determinants in the first intron of the TNF-beta gene. Autoimmunity. 35: 377-80. PMID 12568117 DOI: 10.1080/0891693021000021549 |
0.548 |
|
| 2002 |
Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis. Journal of the Neurological Sciences. 202: 93-7. PMID 12220699 DOI: 10.1016/S0022-510X(02)00246-0 |
0.554 |
|
| 2001 |
Modin H, Dai Y, Masterman T, Svejgaard A, Sørensen PS, Oturai A, Ryder LP, Spurkland A, Vartdal F, Laaksonen M, Sandberg-Wollheim M, Myhr KM, Nyland H, Hillert J. No linkage or association of the nitric oxide synthase genes to multiple sclerosis Journal of Neuroimmunology. 119: 95-100. PMID 11525805 DOI: 10.1016/S0165-5728(01)00366-6 |
0.406 |
|
| 2001 |
Vedeler CA, Myhr K, Nyland H. Fc receptors for immunoglobulin G--a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis. Journal of Neuroimmunology. 118: 187-193. PMID 11498253 DOI: 10.1016/S0165-5728(01)00344-7 |
0.579 |
|
| 2001 |
Myhr KM, Riise T, Vedeler C, Nortvedt MW, Grønning M, Midgard R, Nyland HI. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension. Multiple Sclerosis Journal. 7: 59-65. PMID 11321195 DOI: 10.1177/135245850100700110 |
0.305 |
|
| 2000 |
Nortvedt MW, Riise T, Myhr K, Nyland HI. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Medical Care. 38: 1022-1028. PMID 11021675 DOI: 10.1097/00005650-200010000-00006 |
0.508 |
|
| 2000 |
Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurologica Scandinavica. 102: 143-149. PMID 10987373 DOI: 10.1034/J.1600-0404.2000.102003143.X |
0.359 |
|
| 2000 |
Vedeler CA, Raknes G, Myhr K, Nyland H. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology. 55: 705-707. PMID 10980740 DOI: 10.1212/Wnl.55.5.705 |
0.551 |
|
| 2000 |
Nortvedt MW, Riise T, Myhr K, Nyland HI. Quality of life as a predictor for change in disability in MS Neurology. 55: 51-54. PMID 10891905 DOI: 10.1212/Wnl.55.1.51 |
0.542 |
|
| 2000 |
Raknes G, Fernandes Filho JA, Pandey JP, Myhr KM, Ulvestad E, Nyland H, Vedeler CA. IgG allotypes and subclasses in Norwegian patients with multiple sclerosis. Journal of the Neurological Sciences. 175: 111-5. PMID 10831771 DOI: 10.1016/S0022-510X(00)00292-6 |
0.431 |
|
| 1999 |
Nortvedt MW, Riise T, Myhr K, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 53: 1098-1098. PMID 10496273 DOI: 10.1212/Wnl.53.5.1098 |
0.563 |
|
| 1999 |
Myhr K, Raknes G, Nyland H, Vedeler C. Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS Neurology. 52: 1771-1771. PMID 10371522 DOI: 10.1212/Wnl.52.9.1771 |
0.625 |
|
| 1998 |
Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H. Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway. Journal of Neurology, Neurosurgery, and Psychiatry. 64: 539-42. PMID 9576551 DOI: 10.1136/Jnnp.64.4.539 |
0.564 |
|
| 1997 |
Vedeler CA, Wik E, Nyland H. The long-term prognosis of Guillain-Barré syndrome. Evaluation of prognostic factors including plasma exchange. Acta Neurologica Scandinavica. 95: 298-302. PMID 9188906 DOI: 10.1111/J.1600-0404.1997.Tb00214.X |
0.359 |
|
| 1997 |
Gusev E, Sudomoina M, Boiko A, Vartdal F, Spurkland A, Nyland H, Myhr K-, Demina T, Turetskaya R, Favorova O. 4-31-11 TNFa1 allele is associated with multiple sclerosis both in Russian and Norwegian caucasians Journal of the Neurological Sciences. 150. DOI: 10.1016/S0022-510X(97)86102-3 |
0.342 |
|
| 1996 |
Nyland H, Myhr KM, Lillås F, Smievoll AI, Riise T, Nortvedt M, Nilsen R. Treatment of relapsing-remittent multiple sclerosis with recombinant human interferon-alfa-2a: design of a randomised, placebo-controlled, double blind trial in Norway Multiple Sclerosis Journal. 1: 372-375. PMID 9345420 DOI: 10.1177/135245859600100618 |
0.315 |
|
| 1996 |
Midgard R, Riise T, Nyland H. Impairment, disability, and handicap in multiple sclerosis. A cross-sectional study in an incident cohort in Møre and Romsdal County, Norway. Journal of Neurology. 243: 337-44. PMID 8965107 DOI: 10.1007/BF00868408 |
0.333 |
|
| 1996 |
Landtblom A, Sjöqvist L, Söderfeldt B, Nyland H, Thuomas K-. Proton MR Spectroscopy and MR Imaging in Acute and Chronic Multiple Sclerosis — Ringlike Appearances in Acute Plaques Acta Radiologica. 37: 278-287. PMID 8845254 DOI: 10.1177/02841851960371P160 |
0.383 |
|
| 1996 |
Vaughan JH, Riise T, Rhodes GH, Nguyen M-, Barrett-Connor E, Nyland H. An Epstein Barr virus-related cross reactive autoimmune response in multiple sclerosis in Norway. Journal of Neuroimmunology. 69: 95-102. PMID 8823380 DOI: 10.1016/0165-5728(96)00069-0 |
0.418 |
|
| 1996 |
Midgard R, Riise T, Svanes C, Kvåle G, Nyland H. Incidence of multiple sclerosis in Møre and Romsdal, Norway from 1950 to 1991. An age-period-cohort analysis. Brain. 119: 203-211. PMID 8624682 DOI: 10.1093/Brain/119.1.203 |
0.336 |
|
| 1995 |
Midgard R, Albrektsen G, Riise T, Kvåle G, Nyland H. Prognostic factors for survival in multiple sclerosis: a longitudinal, population based study in Møre and Romsdal, Norway. Journal of Neurology, Neurosurgery, and Psychiatry. 58: 417-421. PMID 7738546 DOI: 10.1136/Jnnp.58.4.417 |
0.401 |
|
| 1995 |
Midgard R, Glattre E, Grønning M, Riise T, Edland A, Nyland H. Multiple sclerosis and cancer in Norway. A retrospective cohort study Journal of Neuroimmunology. 56: 69-69. DOI: 10.1016/0165-5728(95)99102-O |
0.32 |
|
| 1994 |
Naess A, Halstensen A, Nyland H, Pedersen SHJ, Moller P, Borgmann R, Larsen JL, Haga E. Sequelae one year after meningococcal disease Acta Neurologica Scandinavica. 89: 139-142. PMID 8191877 DOI: 10.1111/J.1600-0404.1994.Tb01649.X |
0.313 |
|
| 1994 |
Bö L, Mörk S, Kong PA, Nyland H, Pardo CA, Trapp BD. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. Journal of Neuroimmunology. 51: 135-46. PMID 8182113 DOI: 10.1016/0165-5728(94)90075-2 |
0.32 |
|
| 1994 |
Myhr KM, Frost P, Grønning M, Midgard R, Kalland KH, Helland DE, Nyland HI. Absence of HTLV-1 related sequences in MS from high prevalence areas in western Norway. Acta Neurologica Scandinavica. 89: 65-8. PMID 8178631 DOI: 10.1111/j.1600-0404.1994.tb01634.x |
0.314 |
|
| 1994 |
Ulvestad E, Williams K, Vedeler C, Antel J, Nyland H, Mørk S, Matre R. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. Journal of the Neurological Sciences. 121: 125-131. PMID 8158203 DOI: 10.1016/0022-510X(94)90340-9 |
0.372 |
|
| 1994 |
Vedeler C, Ulvestad E, Nyland H, Matre R, Aarli JA. Receptors for gammaglobulin in the central and peripheral nervous system Journal of Neurology, Neurosurgery, and Psychiatry. 57: 9-10. PMID 7964862 DOI: 10.1136/Jnnp.57.Suppl.9 |
0.493 |
|
| 1994 |
Brokstad KA, Kalland KH, Haaheim L, Page M, Nyland H. Serum antibodies from MS patients do not recognize HTLV‐I, HIV‐1, HIV‐2 and SIV Apmis. 102: 514-520. PMID 7917220 DOI: 10.1111/J.1699-0463.1994.Tb05199.X |
0.403 |
|
| 1993 |
Grønning M, Riise T, Kvåle G, Albrektsen G, Midgard R, Nyland H. Infections in Childhood and Adolescence in Multiple Sclerosis. A Case-Control Study Neuroepidemiology. 12: 61-69. PMID 8232705 DOI: 10.1159/000110302 |
0.348 |
|
| 1992 |
Riise T, Gronning M, Fernandez O, Lauer K, Midgard R, Minderhoud JM, Nyland H, Palffy G, Poser S, Aarli JA. Early prognostic factors for disability in multiple sclerosis, a European multicenter study Acta Neurologica Scandinavica. 85: 212-218. PMID 1575007 DOI: 10.1111/J.1600-0404.1992.Tb04031.X |
0.6 |
|
| 1992 |
Hillert J, Grönning M, Nyland H, Link H, Olerup O. An immunogenetic heterogeneity in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 55: 887-890. PMID 1359021 DOI: 10.1136/Jnnp.55.10.887 |
0.401 |
|
| 1991 |
Grønning M, Riise T, Kvåle G, Nyland H, Larsen JP, Aarli JA. Incidence of multiple sclerosis in Hordaland, western Norway: a fluctuating pattern. Neuroepidemiology. 10: 53-61. PMID 2062418 DOI: 10.1159/000110247 |
0.612 |
|
| 1991 |
Midgard R, Riise T, Nyland H. Epidemiologic trends in multiple sclerosis in Møre and Romsdal, Norway A prevalence/incidence study in a stable population Neurology. 41: 887-887. PMID 2046935 DOI: 10.1212/Wnl.41.6.887 |
0.427 |
|
| 1991 |
Todnem K, Nyland H, Skeidsvoll H, Svihus R, Rinck P, Kambestad BK, Riise T, Aarli JA. Neurological long term consequences of deep diving. Occupational and Environmental Medicine. 48: 258-266. PMID 2025592 DOI: 10.1136/Oem.48.4.258 |
0.543 |
|
| 1991 |
Fredman P, Vedeler CA, Nyland H, Aarli JA, Svennerholm L. Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin. Journal of Neurology. 238: 75-79. PMID 1856740 DOI: 10.1007/Bf00315684 |
0.549 |
|
| 1991 |
Riise T, Grønning M, Klauber MR, Barrett-Connor E, Nyland H, Albrektsen G. Clustering of residence of multiple sclerosis patients at age 13 to 20 years in Hordaland, Norway. American Journal of Epidemiology. 133: 932-9. PMID 1851394 DOI: 10.1093/Oxfordjournals.Aje.A115972 |
0.326 |
|
| 1991 |
Gronning M, Nyland H, Hillert J, Albrektsen G. Tonsillectomy and bacterial serum antibodies in multiple sclerosis patients: A case-control study Journal of Neuroimmunology. 35: 185. DOI: 10.1016/0165-5728(91)91192-F |
0.358 |
|
| 1991 |
Hillert J, Grönning M, Nyland H, Link H, Olerup O. An immunogenetic heterogeneity in multiple sclerosis Journal of Neuroimmunology. 35: 15. DOI: 10.1016/0165-5728(91)90856-3 |
0.397 |
|
| 1990 |
Todnem K, Nyland H, Kambestad BK, Aarli JA. Influence of occupational diving upon the nervous system: an epidemiological study. Occupational and Environmental Medicine. 47: 708-714. PMID 2171631 DOI: 10.1136/Oem.47.10.708 |
0.53 |
|
| 1989 |
Todnem K, Nyland H, Dick APK, Lind O, Svihus R, Molvær OI, Aarli JA. Immediate neurological effects of diving to a depth of 360 metres Acta Neurologica Scandinavica. 80: 333-340. PMID 2816291 DOI: 10.1111/J.1600-0404.1989.Tb03889.X |
0.511 |
|
| 1989 |
Todnem K, Knudsen G, Riise T, Nyland H, Aarli JA. The non-linear relationship between nerve conduction velocity and skin temperature. Journal of Neurology, Neurosurgery, and Psychiatry. 52: 497-501. PMID 2738592 DOI: 10.1136/Jnnp.52.4.497 |
0.484 |
|
| 1989 |
Haaheim LR, Grønning M, Nyland H. Antibodies in sera from Norwegian multiple sclerosis patients and the general population reacting with HTLV‐I Apmis. 97: 767-773. PMID 2571350 DOI: 10.1111/J.1699-0463.1989.Tb00476.X |
0.357 |
|
| 1989 |
Nyland H, Naess A, Eidsvik S, Glette J, Matre R, Hordnes C. Effect of hyperbaric oxygen treatment on immunological parameters in multiple sclerosis. Acta Neurologica Scandinavica. 79: 306-310. PMID 2499161 DOI: 10.1111/J.1600-0404.1989.Tb03790.X |
0.363 |
|
| 1988 |
Osterman PO, Vedeler CA, Ryberg B, Fagius J, Nyland H. Serum antibodies to peripheral nerve tissue in acute Guillain-Barré syndrome in relation to outcome of plasma exchange. Journal of Neurology. 235: 285-289. PMID 3385444 DOI: 10.1007/Bf00314175 |
0.329 |
|
| 1988 |
Riise T, Grønning M, Aarli JA, Nyland H, Larsen JP, Edland A. Prognostic factors for life expectancy in multiple sclerosis analysed by Journal of Clinical Epidemiology. 41: 1031-1036. PMID 3193137 DOI: 10.1016/0895-4356(88)90041-8 |
0.589 |
|
| 1988 |
Vedeler CA, Matre R, Nyland H. Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy. Acta Neurologica Scandinavica. 78: 401-407. PMID 2464267 DOI: 10.1111/J.1600-0404.1988.Tb03676.X |
0.322 |
|
| 1986 |
Vedeler CA, Matre R, Nyland H. Immunoglobulins in serum and cerebrospinal fluid from patients with acute Guillain-Barré syndrome Acta Neurologica Scandinavica. 73: 388-393. PMID 3727914 DOI: 10.1111/J.1600-0404.1986.Tb03294.X |
0.309 |
|
| 1986 |
Naess A, Nyland H, Glette J, Larsen JP, Rygh T, Solberg CO. Granulocyte function in patients with multiple sclerosis. Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section C, Immunology. 94: 89-90. PMID 2943114 DOI: 10.1111/J.1699-0463.1986.TB02095.X |
0.32 |
|
| 1985 |
Larsen JP, Aarli JA, Nyland H. Epidemiological studies on multiple sclerosis Neurology. 35: 1529-1529. DOI: 10.1212/Wnl.35.10.1529-A |
0.61 |
|
| 1984 |
Larsen JP, Aarli JA, Nyland H, Riise T. Western Norway, a high‐risk area for multiple sclerosis A prevalence/incidence study in the county of Hordaland Neurology. 34: 1202-1202. PMID 6540405 DOI: 10.1212/Wnl.34.9.1202 |
0.618 |
|
| 1984 |
Nyland H, Vedeler CA, Matre R, Halvorsen K, Fagius J, Osterman PO, Janzen RWC, Skre H. Plasma exchange in patients with Guillain-Barré syndrome: clinical improvement in patients with serum IgG antibodies to peripheral nerve tissue. International Journal of Artificial Organs. 7: 133-136. DOI: 10.1177/039139888400700306 |
0.342 |
|
| 1983 |
Nyland H, Aasjord P. Humoral and cellular immune responses to staphylococcal lipoteichoic acid in multiple sclerosis patients. Progress in Brain Research. 59: 345-354. PMID 6607483 DOI: 10.1016/S0079-6123(08)63880-7 |
0.367 |
|
| 1982 |
Vedeler CA, Nyland H, Matre R. Antibodies to peripheral nerve tissue in sera from patients with acute Guillain-Barré syndrome demonstrated by a mixed haemagglutination technique Journal of Neuroimmunology. 2: 209-214. PMID 7085862 DOI: 10.1016/0165-5728(82)90055-8 |
0.325 |
|
| 1982 |
Nyland H, Mörk S, Matre R. In-Situ Characterization Of Mononuclear Cell Infiltrates In Lesions Of Multiple Sclerosis Neuropathology and Applied Neurobiology. 8: 403-411. PMID 6983662 DOI: 10.1111/J.1365-2990.1982.Tb00308.X |
0.339 |
|
| 1982 |
Tönnessen TI, Nyland H, Aarli JA. Complement factors and acute phase reactants in the Guillain-Barré syndrome. European Neurology. 21: 124-128. PMID 6920298 DOI: 10.1159/000115467 |
0.516 |
|
| 1982 |
Vedeler CA, Nyland H, Fagius J, Osterman PO, Matre R, Aarli JA, Janzen RWC, Jacobsen H, Skre H. The clinical effect and the effect on serum IgG antibodies to peripheral nerve tissue of plasma exchange in patients with Guillain-Barré syndrome Journal of Neurology. 228: 59-64. PMID 6184459 DOI: 10.1007/Bf00313410 |
0.554 |
|
| Show low-probability matches. |